Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2013
01/17/2013WO2012149245A3 Genomic signatures of metastasis in prostate cancer
01/17/2013WO2012144826A3 System for detecting biomolecule interaction, and detection method using same
01/17/2013WO2012129360A3 Isolation and characterization of tumor cells using shear stress measurements
01/17/2013WO2012107841A3 Micro -rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof
01/17/2013WO2012083240A3 Oligonucleotide array for tissue typing
01/17/2013US20130019350 Methods and Compositions for Selecting Corn Plants Resistant to Diplodia Ear Rot
01/17/2013US20130019345 Florigen-activating complex
01/17/2013US20130019342 Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof
01/17/2013US20130019337 Lettuce variety 79-82 rz
01/17/2013US20130019336 Lettuce variety 79-176 rz
01/17/2013US20130019335 Lettuce variety 79-02 rz
01/17/2013US20130019334 Corn event mzdt09y
01/17/2013US20130019327 Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein
01/17/2013US20130019326 Compositions, Kits, and Methods for Identification, Assessment, Prevention, and Therapy of Metabolic Disorders
01/17/2013US20130018088 Methods and compositions for anti-egfr treatment
01/17/2013US20130018083 Use of sirna targetting sipa1l1 for the reduction of adipogenesis
01/17/2013US20130018024 Methods and systems for pharmacogenomic treatment of cardiovascular conditions
01/17/2013US20130018001 Methods of diagnosing cancer
01/17/2013US20130017977 Microarray Synthesis and Assembly of Gene-Length Polynucleotides
01/17/2013US20130017975 Single nucleotide polymorphism for predicting prognosis of hepatocellular carcinoma
01/17/2013US20130017965 Osteoarthritis biomarkers and uses thereof
01/17/2013US20130017964 Methods to Identify Chronic Lymphocytic Leukemia Disease Progression
01/17/2013US20130017962 Methods and compositions for correlating genetic markers with cardiovascular disease
01/17/2013US20130017569 Culture medium, method for culturing listeria, and method for detecting listeria
01/17/2013US20130017568 Inoculation Loop Devices Having an Angled End and Methods of Making and Using the Same
01/17/2013US20130017565 Methods and products related to low molecular weight heparin
01/17/2013US20130017564 Bioprinting station, assembly comprising such bioprinting station and bioprinting method
01/17/2013US20130017557 COMBINATION OF sPLA2 TYPE IIA MASS AND OXPL/APOB CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT
01/17/2013US20130017552 Method and kit for separating viral and prokaryotic nucleic acids from eukaryotic nucleic acids
01/17/2013US20130017550 Map kinase kinase kinase kinase 3 (map4k3) as a biomarker and therapetic target for autoimmune disease, cancer, inflammation and il-17-associated disease
01/17/2013US20130017549 Method of amplifying target nucleic acid with reduced amplification bias and method for determining relative amount of target nucleic acid in sample
01/17/2013US20130017548 Screening method
01/17/2013US20130017547 Organ-specific feline endothelial cells and uses thereof
01/17/2013US20130017546 Breast Tumor Markers and Methods of Use Thereof
01/17/2013US20130017545 Apparatus and methods for acquiring analytes from a dried biological fluid sample
01/17/2013US20130017544 High Resolution Melting Analysis on a Droplet Actuator
01/17/2013US20130017543 Method and Kit for Amplifying and Detecting Polynucleotide
01/17/2013US20130017542 Method and Kit for Amplifying and Detecting Polynucleotide
01/17/2013US20130017541 Methods and Compositions for Segregating Target Nucleic Acid from Mixed Nucleic Acid Samples
01/17/2013US20130017540 Identification of mutation types associated with acquired resistance and methods for using same
01/17/2013US20130017539 Methods and compositions for chlamydia trachomatis diagnostic testing
01/17/2013US20130017538 Devices, systems, and methods for magnetic separation
01/17/2013US20130017537 Method of in-vitro immunoassay
01/17/2013US20130017536 Western blot kit for detection of vaccinated poultry
01/17/2013US20130017535 Instrument and process for the automated processing of liquid samples
01/17/2013US20130017221 Primers for detecting plasmodium
01/17/2013US20130017217 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
01/17/2013US20130017214 Bacteremia-associated antigen from staphylococcus aureus
01/17/2013US20130017205 Inhibition of AXL Signaling in Anti-Metastatic Therapy
01/17/2013US20130017204 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae
01/17/2013US20130017203 Methods of treating and preventing staphylococcus aureus infections and associated conditions
01/17/2013US20130017198 Manipulation of calcium channels to regulate after-depolarization events in cardiac myocytes
01/17/2013US20130017180 Platelet rich plasma formulations
01/17/2013US20130017179 Lineage-Restricted Neuronal Precursors
01/17/2013US20130015078 Method for measuring substrate concentration
01/17/2013US20130015063 Device for measuring substrate concentration
01/17/2013DE102012013810B4 Nachweis von vermehrungsfähigen Zellen, die auf ein Erzeugnisgemisch reagieren Detection of viable cells that react to a product mixture
01/17/2013DE102008000715B9 Verfahren zur in vitro Erfasssung und Unterscheidung von pathophysiologischen Zuständen Method for the in vitro differentiation of pathophysiological states and Erfasssung
01/17/2013CA2841822A1 Culture medium, method for culturing salmonella and e. coli and method for detecting salmonella and e. coli
01/17/2013CA2841820A1 Culture medium, method for culturing listeria, and method for detecting listeria
01/17/2013CA2841548A1 Sumoylation of serca2a and cardiovascular disease
01/17/2013CA2841543A1 Stacked herbicide tolerance event 8264.42.32.1, related transgenic soybean lines, and detection thereof
01/17/2013CA2841536A1 A new classifier for the molecular classification of multiple myeloma
01/17/2013CA2841484A1 Nmr methods for monitoring blood clot formation
01/17/2013CA2841475A1 Identifying affinity-matured human antibodies
01/17/2013CA2841019A1 Container for nucleic acid amplification reaction
01/17/2013CA2840929A1 Sequence based genotyping based on oligonucleotide ligation assays
01/17/2013CA2840149A1 Methods and nucleic acids for determining the prognosis of a cancer subject
01/16/2013EP2546651A1 Modulator compounds of the drug resistance in epithelial tumour cells
01/16/2013EP2546365A1 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
01/16/2013EP2546364A1 Specialized oligonucleotides and their use in nucleic acid amplification and detection
01/16/2013EP2546363A1 Method and kit for amplifying and detecting polynucleotide
01/16/2013EP2546362A1 Method and kit for amplifying and detecting polynucleotide
01/16/2013EP2546361A1 Method of amplifying target nucleic acid with reduced amplification bias and method for determining relative amount of target nucleic acid in sample
01/16/2013EP2546360A1 Self-assembled single molecule arrays and uses thereof
01/16/2013EP2546359A1 Effects of inhibitors of FGFR3 on gene transcription
01/16/2013EP2546358A1 Methods and reagents for efficient control of HIV progression
01/16/2013EP2546357A1 A new classifier for the molecular classification of multiple myeloma.
01/16/2013EP2546356A1 Methods for Regulation of Stem Cells
01/16/2013EP2546355A1 Methods for identifying diabetes and obesity therapeutics
01/16/2013EP2546344A2 Primer and probe for detecting chlamydophilia caviae, as well as chlamydophilia caviae detection method using the same
01/16/2013EP2546342A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof
01/16/2013EP2546269A1 Monoclonal antibody against necrosis marker prdx4 and use thereof
01/16/2013EP2546266A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF
01/16/2013EP2545935A1 HLS-5, a control sumoylation agent
01/16/2013EP2545481A1 A method, an arrangement and a computer program product for analysing a biological or medical sample
01/16/2013EP2545374A2 Optical particle characterization system
01/16/2013EP2545367A2 Magnetic sensor based quantitative binding kinetics analysis
01/16/2013EP2545191A2 Mrna as biomarkers for liver injury or other liver perturbations
01/16/2013EP2545190A1 Detection and quantification of micrornas in the circulation and the use of circulating micrornas as biomarkers for cancer
01/16/2013EP2545189A1 Full cold-pcr enrichment with reference blocking sequence
01/16/2013EP2545188A1 Detection of methylated dna
01/16/2013EP2545187A1 Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy
01/16/2013EP2545186A1 Androgen receptor isoforms and methods
01/16/2013EP2545185A1 Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes
01/16/2013EP2545184A1 ACTIVITY BASED PROBES (ABPs) INTERACTING WITH GLYCOSIDASES
01/16/2013EP2545172A2 Methods of testing for intracellular pathogens
01/16/2013EP2545163A1 Method of selecting induced pluripotent stem cell
01/16/2013EP2545041A1 Bioluminescent assays using cyanobenzothiazole compounds
01/16/2013EP2544582A1 Method for the electrochemical measurement of an analyte concentration in vivo, and fuel cell for this purpose